Home / Health / AI Labs Invest Millions in Brain Cancer Implant
AI Labs Invest Millions in Brain Cancer Implant
21 Oct
Summary
- Coherence Neuro is developing AI-powered brain implants for cancer detection and treatment.
- OpenAI's venture arm and Peter Thiel's Founders Fund led the $45 million seed funding.
- The startup aims to use implants to detect tumors and stimulate growth inhibition.
Coherence Neuro, a startup focused on brain-computer interfaces, has secured $45 million in seed funding. This investment round was led by OpenAI's venture capital arm and Peter Thiel's Founders Fund, signaling a growing interest from major AI companies in brain data.
The company is developing an implant designed to detect and treat cancer by analyzing subtle electrical signals from the brain. Coherence has already conducted brief tests in human patients undergoing surgery and is planning further trials.
This advanced implant is intended to identify early signs of cancer and potentially halt its growth through mild electrical stimulation. Coherence plans to launch a clinical trial for glioblastoma patients and aims to expand the technology to treat cancers elsewhere in the body.
